NCT02303015View on ClinicalTrials.gov

Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors

CompletedOBSERVATIONAL
Enrollment

430

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

March 31, 2023

Study Completion Date

June 30, 2023

Conditions
Germ Cell Cancer
Trial Locations (1)

2100

Dept. of Oncology, Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT02303015 - Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors | Biotech Hunter | Biotech Hunter